The Melius initiation is a bullish outlier from a mid-tier accuracy firm, unsupported by insider or institutional consensus. Wait for earnings revision momentum to attract higher-accuracy firms or insider buying before positioning.
Price Chart
Executive Summary
Melius Research initiates coverage on Micron (MU) with a Buy rating and $700 price target, implying 40.9% upside from the current $496.72. The firm's 60% accuracy rate (49/82 calls) is below the 15-firm average of 81%, and its PT is 31.1% above the consensus mean of $533.73. Analyst momentum is strong: 1 upgrade and 0 downgrades in the past 30 days, with 25 EPS revisions upward in the last month. Congressional trades are mixed, but insider selling totals $17.6M in the past month. Institutional activity shows divergence: Renaissance Technologies doubled its position, while Wells Fargo trimmed by 56.2%. Short interest is elevated at 41.7% of float. Earnings are due in 57 days, limiting near-term catalyst alignment. This contrarian initiation from a mid-tier accuracy firm lacks cross-confirmation.
Impact Score
Consensus & Targets
Of 40 analysts covering MU, 31 (77.5%) rate Buy, 17 (42.5%) Strong Buy, 3 (7.5%) Hold, and 1 (2.5%) Sell. There are no Strong Sell ratings. The consensus direction remains firmly bullish, with 92.5% of analysts rating Buy or better. Melius joins the majority but with a far more aggressive price target.
The consensus price target mean is $533.73 and median is $546.50, with a high of $852 and low of $249. At $496.72, MU trades 7.4% below the mean target. Melius’s $700 target is 31.1% above the mean and 28.0% above the median, placing it in the top 10% of targets. Implied upside to the mean is 7.4%, but 40.9% to Melius’s target.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-27 | Melius Research | initiate | Buy | $700.00 |
| 2026-04-08 | UBS | maintain | Buy | $535.00 |
| 2026-03-31 | Citigroup | maintain | Buy | $425.00 |
| 2026-03-19 | JP Morgan | maintain | Overweight | $550.00 |
| 2026-03-19 | Mizuho | maintain | Outperform | $530.00 |
| 2026-03-19 | B of A Securities | maintain | Buy | $500.00 |
| 2026-03-19 | Goldman Sachs | maintain | Neutral | $400.00 |
| 2026-03-19 | UBS | maintain | Buy | $510.00 |
| 2026-03-19 | Citigroup | maintain | Buy | $510.00 |
| 2026-03-19 | TD Cowen | maintain | Buy | $550.00 |
In the past 30 days, there has been 1 upgrade and 0 downgrades. EPS estimates are rising sharply: 25 revisions up and 0 down over the past 30 days across all periods. Current-year EPS has increased from $39.12 to $57.95 (+48.1%), and next-year EPS from $62.28 to $101.07 (+62.3%), indicating strong earnings momentum supporting the bullish case.
Firm Track Record — Melius Research
Melius Research accuracy: 60% on 82 calls | avg return: 3.2%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Deutsche Bank | 100% | 4/4 | 57.5% | top tier |
| Citigroup | 92% | 12/13 | 47% | top tier |
| Barclays | 89% | 8/9 | 45.4% | top tier |
| Wells Fargo | 89% | 8/9 | 34.2% | top tier |
| JP Morgan | 86% | 6/7 | 44.2% | top tier |
| UBS | 86% | 12/14 | 40.4% | top tier |
| Mizuho | 85% | 11/13 | 41.3% | top tier |
| Piper Sandler | 80% | 4/5 | 37.4% | top tier |
| Needham | 78% | 7/9 | 39.7% | top tier |
| Goldman Sachs | 75% | 6/8 | 40.2% | top tier |
Melius Research has a 60% accuracy rate (49 correct out of 82 rated calls) with an average return of 3.2%, below the average of the 15 tracked firms (81% accuracy). Top-tier firms like Deutsche Bank (100%, 57.5% avg return) and Citigroup (92%, 47%) have stronger track records. Melius ranks in the bottom third by accuracy and return, reducing the signal’s weight.
Earnings Estimates
Next earnings: Jun 23, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $18.94 | $7.53 — $21.05 | $33.4B | ↑1 ↓0 |
| +1q | $22.48 | $7.68 — $26.90 | $38.9B | ↑2 ↓0 |
| 0y | $57.95 | $28.42 — $64.37 | $108.9B | ↑2 ↓0 |
| +1y | $101.07 | $70.77 — $142.48 | $169.0B | ↑2 ↓0 |
Cross-Platform Signals
Insider activity is bearish: $17.6M in insider sales over the past month, including $10.1M from Sumit Sadana. Institutional flows are mixed: Renaissance Technologies doubled its stake (+151%), while Wells Fargo trimmed by 56.2% and Two Sigma by 37.4%. Norges Bank initiated a new $6.4B position. Congressional trades show minor buys and sells, with no clear trend. Short interest is high at 41.7% of float, suggesting elevated bearish sentiment not yet aligned with analyst upgrades.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | Court Ruling | $955.73 $977.41 | ▲ +2.27% | ▲ +3.23% | $1,083.50 (+13.37%) |
Aug 28, 2026 4w ago | Insider Cluster | $958.73 $1,000.26 | ▲ +4.33% | ▲ +4.47% | $1,083.50 (+13.01%) |
Aug 26, 2026 5w ago | 8-K | $938.40 $956.08 | ▲ +1.88% | ▲ +2.00% | $1,083.50 (+15.46%) |
Aug 25, 2026 5w ago | Insider Cluster | $938.40 $956.08 | ▲ +1.88% | ▲ +2.00% | $1,083.50 (+15.46%) |
Aug 14, 2026 6w ago | ANALYST-UPGRADE | $971.66 $965.17 | ▼ −0.67% | ▲ +0.70% | $1,083.50 (+11.51%) |
Jul 28, 2026 9w ago | Insider Cluster | $739.00 $893.19 | ▲ +20.86% | ▲ +15.34% | $1,083.50 (+46.62%) |
Jul 6, 2026 12w ago | Insider Cluster | $938.38 $983.12 | ▲ +4.77% | ▲ +4.22% | $1,083.50 (+15.46%) |
Jul 6, 2026 12w ago | Court Ruling | $984.75 $979.30 | ▼ −0.55% | ▼ −1.04% | $1,083.50 (+10.03%) |
Jul 2, 2026 13w ago | Insider Cluster | $975.56 $991.64 | ▲ +1.65% | ▲ +0.72% | $1,083.50 (+11.06%) |
Jun 24, 2026 14w ago | 8-K | $1,213.56 $1,032.28 | ▼ −14.94% | ▼ −16.50% | $1,083.50 (−10.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access